Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Completed · Phase 2

Conditions studied: Anxiety Disorder, Depression, Fatigue, Lung Cancer

In brief

This trial is designed to test the efficacy of fluoxetine to improve patient's quality of life during chemotherapy. An innovative application of a selective serotonin reuptake inhibitor may modulate the effects of fatigue, anxiety and depression which worsen quality of life.

Key facts

Study ID
NCT00005850
Run by
Alliance for Clinical Trials in Oncology
People needed
21
Starts
2001-08-01
Expected to finish
2003-09-01
Last updated by the study team
2016-07-04

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.